- $938.34m
- $895.51m
- $81.39m
U.S. STOCKS ON THE MOV-Guardant Health, Tower Semiconductor, GlobalFoundries
U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease
MeiraGTx jumps on collaboration with Lilly for rare eye disease treatment
Brief: MeiraGTx Announces Two Posters At The European Society Of Gene And Cell Therapy (ESGCT) 2025 Annual Congress
Brief: MeiraGTx Q2 EPS USD -0.48
MeiraGTx Holdings PLC expected to post a loss of 47 cents a share - Earnings Preview
Brief: MeiraGTx Receives UK Approval for Hologen Transactions, Closing Expected July 2025
Advisory: Dated alert on MeiraGTx collaboration with Hologen AI withdrawn
MeiraGTx Holdings PLC reports results for the quarter ended March 31 - Earnings Summary
Brief: MeiraGTx Q1 EPS USD -0.51
MeiraGTx Holdings PLC expected to post a loss of 49 cents a share - Earnings Preview
Directorate Change
U.S. STOCKS ON THE MOVE-MeiraGTx, CervoMed, Natgas companies
U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx
MeiraGTx rises on collaboration with Hologen to develop Parkinson's disease therapy
MeiraGTx Holdings PLC reports results for the quarter ended December 31 - Earnings Summary
Brief: MeiraGTx FY EPS USD -2.12
Brief: MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing